Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
A practical guide to mechanical ventilation [Risorsa elettronica] / edited by Jonathon D. Truwit and Scott K. Epstein
| A practical guide to mechanical ventilation [Risorsa elettronica] / edited by Jonathon D. Truwit and Scott K. Epstein |
| Pubbl/distr/stampa | Chichester, West Sussex, UK ; Hoboken, N. J. : Wiley-Blackwell, 2011 |
| Disciplina | 615.836 |
| ISBN | 9780470976609 |
| Formato | Risorse elettroniche  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-990009796040403321 |
| Chichester, West Sussex, UK ; Hoboken, N. J. : Wiley-Blackwell, 2011 | ||
| Risorse elettroniche | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in extra-corporeal perfusion therapies / / Michael S. Firstenberg, editor
| Advances in extra-corporeal perfusion therapies / / Michael S. Firstenberg, editor |
| Pubbl/distr/stampa | [Place of publication not identified] : , : IntechOpen, , [2019] |
| Descrizione fisica | 1 online resource (256 pages) : illustrations |
| Disciplina | 615.836 |
| Soggetto topico |
Extracorporeal membrane oxygenation
Extracorporeal shock wave therapy |
| ISBN |
1-83881-704-2
1-78984-914-4 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317769703321 |
| [Place of publication not identified] : , : IntechOpen, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in extracorporeal membrane oxygenation . Volume 3 / / edited by Michael S. Firstenberg
| Advances in extracorporeal membrane oxygenation . Volume 3 / / edited by Michael S. Firstenberg |
| Pubbl/distr/stampa | London, England : , : IntechOpen, , [2019] |
| Descrizione fisica | 1 online resource (242 pages) : illustrations |
| Disciplina | 615.836 |
| Soggetto topico | Extracorporeal membrane oxygenation |
| ISBN | 1-78923-924-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Advances in Extracorporeal Membrane Oxygenation |
| Record Nr. | UNINA-9910407748703321 |
| London, England : , : IntechOpen, , [2019] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in Extracorporeal Membrane Oxygenation . Volume 3 / / edited by Michael S. Firstenberg
| Advances in Extracorporeal Membrane Oxygenation . Volume 3 / / edited by Michael S. Firstenberg |
| Pubbl/distr/stampa | London : , : IntechOpen, , 2019 |
| Descrizione fisica | 1 online resource (244 pages) |
| Disciplina | 615.836 |
| Soggetto topico | Extracorporeal membrane oxygenation |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Advances in Extracorporeal Membrane Oxygenation |
| Record Nr. | UNINA-9910688586903321 |
| London : , : IntechOpen, , 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Aerosols : science and technology / editor H. R. Shepherd
| Aerosols : science and technology / editor H. R. Shepherd |
| Pubbl/distr/stampa | New York : Interscience publishers, 1961 |
| Descrizione fisica | XIV, 548 p. : ill. ; 23 cm |
| Disciplina | 615.836 |
| Soggetto non controllato | Aerosoli |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158356903321 |
| New York : Interscience publishers, 1961 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemistry and Biochemistry of Oxygen Therapeutics [[electronic resource] ] : From Transfusion to Artificial Blood
| Chemistry and Biochemistry of Oxygen Therapeutics [[electronic resource] ] : From Transfusion to Artificial Blood |
| Autore | Mozzarelli Andrea |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (476 p.) |
| Disciplina |
615.8/36
615.836 |
| Altri autori (Persone) | BettatiStefano |
| Soggetto topico |
Hemoglobins - therapeutic use
Hemoglobins -- therapeutic use Nitric oxide - Physiological effect Nitric oxide -- Physiological effect Oxigen - Physiological effect Oxigen -- Physiological effect Oxygen - blood Oxygen -- blood Oxygen Consumption Oxygen Inhalation Therapy - methods Oxygen Inhalation Therapy -- methods Oxygen therapy SCIENCE / Life Sciences / Biochemistry Oxygen therapy - Physiological effect Oxygen - Physiological effect Nitric oxide Metabolic Phenomena Respiratory Therapy Investigative Techniques Body Fluids Globins Chalcogens Blood Proteins Gases Therapeutics Fluids and Secretions Elements Hemeproteins Inorganic Chemicals Proteins Amino Acids, Peptides, and Proteins Anatomy Oxygen Blood Hemoglobins Methods Oxygen Inhalation Therapy Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-17785-4
9786613177858 1-119-97542-5 1-119-97543-3 |
| Classificazione | SCI007000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Chemistry and Biochemistry of Oxygen Therapeutics; Contents; List of Contributors; Preface; 1. Introduction; References; Part I. Oxygen: Chemistry, Biochemistry, Physiology and Toxicity; 2. Hemoglobin Reactivity and Regulation; 2.1 Introduction; 2.2 Oxygen Loading and Transport; 2.3 NO Reactivity with Hb; 2.4 Hb Oxidation; 2.5 Nitrite Reactivity with Hb; 2.6 Amino-acid Determinants of Hb Reactivity: Natural and Engineered Hbs; 2.6.1 Modulation of Oxygen Affinity and Cooperativity; 2.6.2 NO Reactivity and Oxidation; 2.7 Conclusion; Acknowledgments; References
3. The Major Physiological Control Mechanisms of Blood Flow and Oxygen Delivery3.1 Introduction; 3.2 Autoregulation of Blood Flow to Changes in Perfusion Pressure; 3.3 Metabolic Regulation of Blood Flow; 3.4 O2 Transport; 3.5 O2 Delivery; 3.6 Endothelial Control of Vasomotor Tone; 3.7 Effect of Cell-free Hb on Endothelial Function; 3.8 Hypoxic Hypoxia; 3.9 Carbon Monoxide Hypoxia; 3.10 Anemia; 3.11 Conclusion; References; 4. The Main Players: Hemoglobin and Myoglobin; Nitric Oxide and Oxygen; 4.1 Introduction; 4.2 Role of Mammalian Mb in O2 Homeostasis 4.3 WhatLfs Missing in the Mb Knockout Mouse4.4 Evolutionary Origins of Mb and the Nitrogen Cycle; 4.5 Human Hb: Evolved Sensor of pO2 and Redox; 4.6 Broad Reactivity and Influence of NO: Lessons from the Microcosm Hb; 4.7 Some Fish Demonstrate a Fundamental "Need" for Hb-dependent NO Cycling, as in Humans; 4.8 Reactions of NO with Hb that Preserve NO Bioactivity; 4.9 Mammalian RBC/Hb.NO Interactions; 4.10 A Mutant Mouse Challenges the SNO-Hb Hypothesis, but does not Overthrow it; 4.11 Signaling by Hb-derived SNO: A Metabolically Responsive, Regulated Pathway 4.12 Signaling by Hb-derived SNO: Pathway Complexity Revealed by Multiple Defects in Disease States4.13 Therapeutic Implications of the Hb.NO Signaling System; 4.14 HBOCs, NO, and SNO; 4.15 Other Gaseous Hb Ligands of Potential Therapeutic Significance; 4.16 NO-related Enzymatic Activities of Hb: Reconciling Nitrite Reductase and SNO Synthase Functions; 4.17 Measuring Biologically Relevant Hb.NO Adducts; 4.18 Conclusion; Acknowledgments; References; 5. The Role of Reactive Oxygen and Nitrogen Species in Ischemia/Reperfusion Injury; 5.1 Introduction 5.2 Redox System and Free Radicals in Biological Systems5.3 Pathophysiology of Ischemia/Reperfusion Injury; 5.3.1 Cell Death; 5.3.2 The Inflammatory Response; 5.4 Protection Against I/R Injury; 5.4.1 Ischemic Pre- and Post-conditioning; 5.4.2 Pharmacological Conditioning; 5.4.2.1 The Protective Role of ROS and Antioxidants; 5.4.2.2 The Protective Role of NO; 5.4.2.3 NO-based Therapies for I/R Injury; 5.5 Conclusion; Acknowledgments; References; Part II. Medical Needs for Oxygen Supply; 6. Acute Traumatic Hemorrhage and Anemia; 6.1 Introduction; 6.2 Blood Transfusion in Trauma 6.2.1 Massive Transfusion |
| Record Nr. | UNINA-9910139631203321 |
Mozzarelli Andrea
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemistry and Biochemistry of Oxygen Therapeutics : From Transfusion to Artificial Blood
| Chemistry and Biochemistry of Oxygen Therapeutics : From Transfusion to Artificial Blood |
| Autore | Mozzarelli Andrea |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (476 p.) |
| Disciplina |
615.8/36
615.836 |
| Altri autori (Persone) | BettatiStefano |
| Soggetto topico |
Hemoglobins - therapeutic use
Hemoglobins -- therapeutic use Nitric oxide - Physiological effect Nitric oxide -- Physiological effect Oxigen - Physiological effect Oxigen -- Physiological effect Oxygen - blood Oxygen -- blood Oxygen Consumption Oxygen Inhalation Therapy - methods Oxygen Inhalation Therapy -- methods Oxygen therapy SCIENCE / Life Sciences / Biochemistry Oxygen therapy - Physiological effect Oxygen - Physiological effect Nitric oxide Metabolic Phenomena Respiratory Therapy Investigative Techniques Body Fluids Globins Chalcogens Blood Proteins Gases Therapeutics Fluids and Secretions Elements Hemeproteins Inorganic Chemicals Proteins Amino Acids, Peptides, and Proteins Anatomy Oxygen Blood Hemoglobins Methods Oxygen Inhalation Therapy Health & Biological Sciences Pharmacy, Therapeutics, & Pharmacology |
| ISBN |
1-283-17785-4
9786613177858 1-119-97542-5 1-119-97543-3 |
| Classificazione | SCI007000 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Chemistry and Biochemistry of Oxygen Therapeutics; Contents; List of Contributors; Preface; 1. Introduction; References; Part I. Oxygen: Chemistry, Biochemistry, Physiology and Toxicity; 2. Hemoglobin Reactivity and Regulation; 2.1 Introduction; 2.2 Oxygen Loading and Transport; 2.3 NO Reactivity with Hb; 2.4 Hb Oxidation; 2.5 Nitrite Reactivity with Hb; 2.6 Amino-acid Determinants of Hb Reactivity: Natural and Engineered Hbs; 2.6.1 Modulation of Oxygen Affinity and Cooperativity; 2.6.2 NO Reactivity and Oxidation; 2.7 Conclusion; Acknowledgments; References
3. The Major Physiological Control Mechanisms of Blood Flow and Oxygen Delivery3.1 Introduction; 3.2 Autoregulation of Blood Flow to Changes in Perfusion Pressure; 3.3 Metabolic Regulation of Blood Flow; 3.4 O2 Transport; 3.5 O2 Delivery; 3.6 Endothelial Control of Vasomotor Tone; 3.7 Effect of Cell-free Hb on Endothelial Function; 3.8 Hypoxic Hypoxia; 3.9 Carbon Monoxide Hypoxia; 3.10 Anemia; 3.11 Conclusion; References; 4. The Main Players: Hemoglobin and Myoglobin; Nitric Oxide and Oxygen; 4.1 Introduction; 4.2 Role of Mammalian Mb in O2 Homeostasis 4.3 WhatLfs Missing in the Mb Knockout Mouse4.4 Evolutionary Origins of Mb and the Nitrogen Cycle; 4.5 Human Hb: Evolved Sensor of pO2 and Redox; 4.6 Broad Reactivity and Influence of NO: Lessons from the Microcosm Hb; 4.7 Some Fish Demonstrate a Fundamental "Need" for Hb-dependent NO Cycling, as in Humans; 4.8 Reactions of NO with Hb that Preserve NO Bioactivity; 4.9 Mammalian RBC/Hb.NO Interactions; 4.10 A Mutant Mouse Challenges the SNO-Hb Hypothesis, but does not Overthrow it; 4.11 Signaling by Hb-derived SNO: A Metabolically Responsive, Regulated Pathway 4.12 Signaling by Hb-derived SNO: Pathway Complexity Revealed by Multiple Defects in Disease States4.13 Therapeutic Implications of the Hb.NO Signaling System; 4.14 HBOCs, NO, and SNO; 4.15 Other Gaseous Hb Ligands of Potential Therapeutic Significance; 4.16 NO-related Enzymatic Activities of Hb: Reconciling Nitrite Reductase and SNO Synthase Functions; 4.17 Measuring Biologically Relevant Hb.NO Adducts; 4.18 Conclusion; Acknowledgments; References; 5. The Role of Reactive Oxygen and Nitrogen Species in Ischemia/Reperfusion Injury; 5.1 Introduction 5.2 Redox System and Free Radicals in Biological Systems5.3 Pathophysiology of Ischemia/Reperfusion Injury; 5.3.1 Cell Death; 5.3.2 The Inflammatory Response; 5.4 Protection Against I/R Injury; 5.4.1 Ischemic Pre- and Post-conditioning; 5.4.2 Pharmacological Conditioning; 5.4.2.1 The Protective Role of ROS and Antioxidants; 5.4.2.2 The Protective Role of NO; 5.4.2.3 NO-based Therapies for I/R Injury; 5.5 Conclusion; Acknowledgments; References; Part II. Medical Needs for Oxygen Supply; 6. Acute Traumatic Hemorrhage and Anemia; 6.1 Introduction; 6.2 Blood Transfusion in Trauma 6.2.1 Massive Transfusion |
| Record Nr. | UNINA-9910806996303321 |
|
Mozzarelli Andrea
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug delivery to the lung / edited by Hans Bisgaard, Chris O'Callaghan, Gerald C. Smaldone
| Drug delivery to the lung / edited by Hans Bisgaard, Chris O'Callaghan, Gerald C. Smaldone |
| Pubbl/distr/stampa | New York ; Basel : M. Dekker, copyr. 2002 |
| Descrizione fisica | XVI, 511 p. ; 23 cm |
| Disciplina | 615.836 |
| Collana | Lung biology in health and disease |
| Soggetto topico | Aerosolterapia |
| ISBN | 0-8247-0541-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-990001171110203316 |
| New York ; Basel : M. Dekker, copyr. 2002 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Essentials of aerosol therapy in critically ill patients / / Haitham Saeed [and three others]
| Essentials of aerosol therapy in critically ill patients / / Haitham Saeed [and three others] |
| Autore | Saeed Haitham |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (245 pages) |
| Disciplina | 615.836 |
| Soggetto topico |
Aerosol therapy
Critical care medicine Internal medicine Aerosolteràpia Medicina intensiva |
| Soggetto genere / forma | Llibres electrònics |
| ISBN | 3-030-85026-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Preface -- Contents -- Abbreviations -- Chapter 1: The Type of Patients Requiring Aerosol Therapy (to Treat What and Where?) -- 1.1 Introduction -- 1.2 Differences Between Pediatrics and Adults Influencing Aerosol Delivery -- 1.3 Diseases Treated by Aerosol Therapy -- 1.3.1 Asthma -- 1.3.1.1 Asthma Diagnosis -- 1.3.1.2 Asthma Phenotypes -- 1.3.1.3 Asthma Management -- Non-pharmacological Treatment -- Pharmacological Treatment -- 1.3.1.4 Asthma Exacerbations -- Prevention of Exacerbations -- Management of Asthma Exacerbations -- 1.3.2 Chronic Obstructive Pulmonary Disease -- 1.3.2.1 COPD Diagnosis -- 1.3.2.2 Differences Between COPD and Asthma Diagnosis -- 1.3.2.3 Management of Stable COPD -- 1.3.2.4 Management of COPD Exacerbations -- References -- Chapter 2: Types of Mechanical Ventilation -- 2.1 Mechanical Ventilation -- 2.2 Non-invasive Ventilation -- 2.3 Non-invasive Negative Pressure Ventilation -- 2.4 Non-invasive Positive Pressure Ventilation -- 2.5 Ventilation Modes -- 2.6 Configuration of NIV Circuit -- 2.7 Invasive Ventilation -- 2.8 Endotracheal Intubation -- 2.9 Tracheostomy -- 2.10 Complications of Mechanical Ventilation -- 2.11 Acute Respiratory Distress Syndrome (ARDS) -- 2.12 Ventilator-Associated Pneumonia (VAP) -- 2.13 Pneumothorax -- 2.14 Atelectasis -- 2.15 Pulmonary Edema -- 2.16 Pleural Effusion -- References -- Chapter 3: Oxygen Delivery Systems and Nasally Ventilated Patients -- 3.1 Introduction -- 3.2 Oxygen Device -- 3.3 Clinical Benefits Offered by HFNC -- 3.3.1 Improvement of Mucociliary Clearance -- 3.3.2 Anatomical Dead Space Washout -- 3.3.3 Positive End-Expiratory Pressure (PEEP) Effect -- 3.3.4 Provision of the Stable Fraction of Inspired Oxygen -- 3.4 Attenuation of Inspiratory Resistance (Work of Breathing) -- 3.4.1 By Providing Adequate Flow -- 3.4.2 By Supplying Adequately Heated and Humidified Gas.
3.4.2.1 Potential Clinical HFNC Applications -- 3.5 Obstructive Airways Diseases -- 3.6 Hypoxemic Respiratory Failure -- 3.7 Hypercapnic Respiratory Failure -- 3.8 Acute Cardiogenic Pulmonary Edema (ACPE) -- 3.9 Respiratory Infection -- 3.10 Post-extubation -- 3.11 Do-Not-Intubate Patients and Palliative Care -- 3.12 Home Oxygen Therapy or Long Term Oxygen Therapy (LTOT) -- 3.13 Oxygen Concentrators -- 3.14 Compressed Gas Cylinders -- 3.15 Liquid Oxygen Systems -- References -- Chapter 4: Special Needs for Neonates, Infants, and Toddler -- 4.1 Introduction -- 4.2 Differences Between Pediatric and Adult Patients in the Delivery of Inhaled Medications -- 4.3 Age Is a Factor for Choosing the Best Aerosol-Generating Device -- 4.4 Patient-Related Factors -- 4.5 Selection of Aerosol-Generating Devices -- 4.6 Aerosol Generating Devices -- 4.7 Nebulizers -- 4.7.1 Jet Nebulizer -- 4.7.2 Ultrasonic Nebulizers -- 4.7.3 Vibrating Mesh Nebulizers -- 4.8 Pressurized Metered-Dose Inhalers -- 4.9 Dry Powder Inhalers -- 4.10 Selection of Aerosol Therapy Interface -- 4.11 Valved Holding Chamber and Spacers -- References -- Chapter 5: Transitioning Aerosol from Hospital to Home -- Role of Training and Follow-Up -- 5.1 Challenges of Aerosol Therapy -- 5.2 Factors Affecting Adherence to Aerosol Therapy -- 5.2.1 The Aerosol Generating Devices -- 5.2.2 Drug-Related Factors -- 5.2.3 Healthcare Professional Related Factors -- 5.3 Factors Related to the Patient -- 5.4 Role of Counseling in Patient Adherence -- 5.4.1 Counseling Sessions -- 5.5 Patient Preference-Based Inhaler Selection -- 5.5.1 Inhaler Labeling -- 5.5.2 Aerosol Therapies Follow Up -- 5.5.3 Evaluation of Patient Inhaler Usage Technique -- 5.5.4 Inhalation Manager -- 5.5.5 Aerosol Inhalations Monitor (AIM) -- 5.5.6 Mag-Flo Inhaler -- 5.5.7 Turbutest -- 5.5.8 2Tone Trainer -- 5.5.9 In-Check DIAL. 5.5.10 Trainhaler and Flo-Tone -- 5.5.11 Clip-Tone E -- 5.6 Monitoring Patient Adherence to Aerosol Therapy -- 5.7 Clinical Judgment on Therapy -- 5.8 Self-Reports by Patients -- 5.9 Electronic Monitoring Device -- 5.10 Laboratory Measurements of Medications and Response -- 5.11 Pharmacy Registered Data -- 5.12 Assessment Tools for Aerosol Therapy and Disease Control -- 5.12.1 Questionnaires in Asthma -- 5.12.2 Asthma Control Questionnaire -- 5.12.3 Asthma Control Test -- 5.12.4 Asthma Therapy Assessment Questionnaire (ATAQ) -- 5.12.5 Test for Respiratory and Asthma Control in Kids -- 5.12.6 Questionnaires for Assessment of COPD -- References -- Chapter 6: The Aerosol Generators Available for Critically Ill Patient -- 6.1 Introduction -- 6.2 Discussion and Analysis of Main Topics -- 6.2.1 Nebulizers -- 6.2.1.1 Air-Jet Nebulizer (JNs) -- 6.2.1.2 Ultrasonic Nebulizers (USNs) -- 6.2.1.3 Vibrating Mesh Nebulizer (VMNs) -- 6.2.2 Pressurized Metered Dose Inhalers (pMDIs) -- 6.2.2.1 Add-on Devices (Spacers) -- 6.2.3 Dry Powder Inhalers (DPIs) -- 6.2.4 Soft Mist Inhalers (SMIs) -- 6.3 Conclusion -- References -- Chapter 7: Mechanisms of Aerosol Lung Deposition -- 7.1 Principles of Aerosol Delivery -- 7.2 Physical Principles that Control Aerosol Delivery and Deposition -- 7.2.1 Particle Size -- 7.2.2 Inertial Impaction -- 7.2.3 Gravitational Sedimentation -- 7.2.4 Brownian Motion and Diffusion -- 7.2.5 Electrostatic Attraction -- 7.2.6 Variables Related to the Patient -- 7.2.7 Deposition in the Oropharyngeal Regions -- 7.3 Oral Deposition for the Dry Powder Inhalers (DPIs) -- 7.3.1 Lung Clearance Mechanisms -- 7.3.2 The Optimal Site for Aerosol Therapy Deposition for Management of Lung Diseases -- 7.4 Optimal Site of Aerosol Therapy Deposition for Management of Systemic Diseases -- References. Chapter 8: Factors Affecting Aerosol Deposition in Critically Ill Patient -- 8.1 Introduction -- 8.2 Discussion and Analysis of Main Topics -- 8.2.1 Ventilator-Related Factors -- 8.2.2 Circuit-Related Factors -- 8.2.3 Device-Related Factors -- 8.2.4 Drug-Related Factors -- 8.2.5 Patient-Related Factors -- 8.3 Conclusion -- References -- Chapter 9: Inhaled Medications Employed in Critically Ill Patients -- 9.1 Introduction -- 9.2 Discussion and Analysis of Main Topics -- 9.2.1 Inhaled Medications Employed During Mechanical Ventilation (MV) -- 9.2.1.1 Bronchodilators -- 9.2.1.2 Prostanoids -- 9.2.1.3 Surfactant -- 9.2.1.4 Antibiotics/Antibacterial -- 9.2.1.5 Antiviral -- 9.2.1.6 Mucolytic Agents -- 9.2.1.7 Corticosteroids -- 9.2.1.8 Miscellaneous -- 9.2.2 Common Applications of Aerosol Therapy in Critical Care -- 9.2.3 Effect of Dosing -- 9.2.4 Effect of Administration Technique -- 9.2.5 Limitations of Aerosol Therapy in Critical Care -- 9.3 Conclusion -- References -- Chapter 10: Aerosol Therapies During High Flow Oxygen Therapy -- 10.1 Introduction -- 10.2 Factors Affecting Aerosol Delivery Within High Flow Oxygen System -- 10.2.1 Flow Rate of Gas -- 10.2.2 The Type of Aerosol Generator and Its Position Within the HFNC Circuit -- 10.2.3 Density of Gas -- 10.2.4 Interface -- References -- Chapter 11: Methods of Detecting Aerosol Delivery to the Lung -- 11.1 Introduction -- 11.2 Particle Size Distribution -- 11.3 Measuring Aerosol Particle Distribution with Inertial Impaction -- 11.4 Twin Stage Impinger -- 11.5 Marple-Miller Cascade Impactor -- 11.6 Multistage Liquid Impinger -- 11.7 Anderson Cascade Impactor -- 11.8 Next-Generation Impactors -- 11.9 Light Diffraction Methods -- 11.10 Laser Diffraction -- 11.11 Pulmonary Function Tests -- 11.12 Spirometry -- 11.13 Models Used for Aerosol Delivery Quantification -- 11.14 In-Vitro Models. 11.15 In-Vitro Determination of Emitted Dose -- 11.16 In-Vitro Model for Characterization of Aerosol Particle Size Via Inertial Impaction -- 11.16.1 In-Vivo Models -- 11.16.2 Pharmacokinetics Model -- 11.16.3 Ex-Vivo Models -- 11.16.4 Imaging Models -- 11.16.5 Data Modeling -- References -- Chapter 12: Monitoring Plans and Weaning Protocols for Critically Ill Patients -- 12.1 Introduction -- 12.2 Discussion and Analysis of Main Topics -- 12.2.1 Monitoring Patient During Invasive Mechanical Ventilation (IMV) -- 12.2.1.1 Monitoring of Ventilator Parameters During IMV -- 12.2.1.2 Monitoring Spontaneous Breathing During IMV -- Monitoring through Esophageal Pressure (Pes) -- Transpulmonary Pressure (PL) -- Inspiratory Muscle Pressure (Pmus) -- Transdiaphragmatic Pressure (Pdi) -- Monitoring Through Occlusion Maneuvers -- Inspiratory Occlusion Maneuver -- Expiratory Occlusion Maneuver -- Airway Occlusion Pressure (P0.1) -- Monitoring Through Electrical Activity of the Diaphragm (EAdi) -- Monitoring Through Diaphragm Ultrasound -- 12.2.1.3 Monitoring of ETT -- 12.2.1.4 Monitoring of TST -- 12.2.2 Weaning from IMV -- 12.2.3 Monitoring of Patient During NIV -- 12.2.3.1 Monitoring of Clinical Parameters During NIV -- 12.2.3.2 Monitoring of Special Laboratory Indices during NIV -- 12.2.3.3 Monitoring of Lung Functions and Ventilator Parameters During NIV -- 12.2.4 Optimizing Ventilator Settings During NIV -- 12.2.5 Weaning from NIV -- 12.3 Conclusion -- References. |
| Record Nr. | UNINA-9910506389503321 |
|
Saeed Haitham
|
||
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Extracorporeal Life Support for Adults / / edited by Gregory A Schmidt
| Extracorporeal Life Support for Adults / / edited by Gregory A Schmidt |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Humana, , 2016 |
| Descrizione fisica | 1 online resource (276 p.) |
| Disciplina | 615.836 |
| Collana | Respiratory Medicine |
| Soggetto topico |
Respiratory organs—Diseases
Critical care medicine Internal medicine Pneumology/Respiratory System Intensive / Critical Care Medicine Internal Medicine |
| ISBN | 1-4939-3005-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Physiology of Extracorporeal Life Support (ECLS), Matthew J. Brain, Warwick W. Butt, Graeme MacLaren -- Hypoxemic Respiratory Failure: Evidence, Indications, Exclusions, Darryl Abrams, Matthew Bacchetta, Daniel Brodie -- Cardiogenic Shock: Evidence, Indications, Exclusions, Nicolas Bréchot, Alain Combes -- ECCO2R in Obstructive Diseases: Evidence, Indications, Exclusions, Lorenzo Del Sorbo, V. Marco Ranieri -- ECLS as a Bridge to Lung Transplantation, Christian Kuehn.- Modes of ECLS, L. Keith Scott, Benjamin Schmidt -- Vascular Access for ECLS, Steven A. Conrad -- Circuits, Membranes, and Pumps, Bradley H. Rosen -- Ventilator Management during ECLS, Antonio Pesenti, Giacomo Bellani, Giacomo Grasselli, Tommaso Mauri -- Daily Care on ECLS, Giles J. Peek -- Crises during ECLS, Cara L. Agerstrand, Linda B. Mongero, Darryl Abrams, Matthew Bacchetta, Daniel Brodie -- Mobilization during ECLS, Gregory A. Schmidt -- ECMO Weaning and Decannulation, Sundar Krishnan and Gregory A. Schmidt -- The Story of ECLS: History and Future, J. Ann Morris, Robert Pollock, Brittany A. Zwischenberger, Cherry Ballard-Croft, Joseph B. Zwischenberger. |
| Record Nr. | UNINA-9910254539903321 |
| New York, NY : , : Springer New York : , : Imprint : Humana, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
